Neofect Co.Ltd (290660) - Net Assets
Based on the latest financial reports, Neofect Co.Ltd (290660) has net assets worth ₩26.86 Billion KRW (≈ $18.20 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩69.30 Billion ≈ $46.97 Million USD) and total liabilities (₩42.44 Billion ≈ $28.76 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Neofect Co.Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩26.86 Billion |
| % of Total Assets | 38.76% |
| Annual Growth Rate | N/A |
| 5-Year Change | 155.22% |
| 10-Year Change | N/A |
| Growth Volatility | 83.89 |
Neofect Co.Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Neofect Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 290660 current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Neofect Co.Ltd (2016–2024)
The table below shows the annual net assets of Neofect Co.Ltd from 2016 to 2024. For live valuation and market cap data, see Neofect Co.Ltd market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩38.90 Billion ≈ $26.36 Million |
+34.45% |
| 2023-12-31 | ₩28.93 Billion ≈ $19.61 Million |
+202.19% |
| 2022-12-31 | ₩9.57 Billion ≈ $6.49 Million |
-22.53% |
| 2021-12-31 | ₩12.36 Billion ≈ $8.37 Million |
-18.92% |
| 2020-12-31 | ₩15.24 Billion ≈ $10.33 Million |
+22.80% |
| 2019-12-31 | ₩12.41 Billion ≈ $8.41 Million |
-56.07% |
| 2018-12-31 | ₩28.25 Billion ≈ $19.15 Million |
+264.38% |
| 2017-12-31 | ₩-17.19 Billion ≈ $-11.65 Million |
-21.36% |
| 2016-12-31 | ₩-14.16 Billion ≈ $-9.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Neofect Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4361845279000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩23.04 Billion | 59.23% |
| Other Components | ₩74.77 Billion | 192.21% |
| Total Equity | ₩38.90 Billion | 100.00% |
Neofect Co.Ltd Competitors by Market Cap
The table below lists competitors of Neofect Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rave Restaurant Group Inc
NASDAQ:RAVE
|
$39.65 Million |
|
Kafein Yazilim
IS:KFEIN
|
$39.68 Million |
|
DP Aircraft I Limited
LSE:DPA
|
$39.68 Million |
|
ENERSIDE ENERGY EO -01
F:9O8
|
$39.69 Million |
|
Winner Group Enterprise Public Company Limited
BK:WINNER
|
$39.65 Million |
|
Pyung Hwa Hldg
KO:010770
|
$39.64 Million |
|
Truong Thanh Furniture Corp
VN:TTF
|
$39.62 Million |
|
Fuel Tech Inc
NASDAQ:FTEK
|
$39.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neofect Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 28,931,488,410 to 38,897,367,040, a change of 9,965,878,630 (34.4%).
- Net loss of 951,433,270 reduced equity.
- Share repurchases of 4,409,740,380 reduced equity.
- New share issuances of 5,999,998,970 increased equity.
- Other factors increased equity by 9,327,053,310.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-951.43 Million | -2.45% |
| Share Repurchases | ₩4.41 Billion | -11.34% |
| Share Issuances | ₩6.00 Billion | +15.43% |
| Other Changes | ₩9.33 Billion | +23.98% |
| Total Change | ₩- | 34.45% |
Book Value vs Market Value Analysis
This analysis compares Neofect Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.26x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩-3017.28 | ₩1159.00 | x |
| 2017-12-31 | ₩-3539.71 | ₩1159.00 | x |
| 2018-12-31 | ₩2087.72 | ₩1159.00 | x |
| 2019-12-31 | ₩908.92 | ₩1159.00 | x |
| 2020-12-31 | ₩806.12 | ₩1159.00 | x |
| 2021-12-31 | ₩653.61 | ₩1159.00 | x |
| 2022-12-31 | ₩337.03 | ₩1159.00 | x |
| 2023-12-31 | ₩748.57 | ₩1159.00 | x |
| 2024-12-31 | ₩923.28 | ₩1159.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neofect Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.51%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.86x
- Recent ROE (-2.45%) is above the historical average (-52.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -298.99% | 0.25x | 0.00x | ₩-4.50 Billion |
| 2017 | 0.00% | -98.54% | 0.44x | 0.00x | ₩-2.67 Billion |
| 2018 | -34.10% | -170.43% | 0.16x | 1.27x | ₩-12.46 Billion |
| 2019 | -127.66% | -128.70% | 0.26x | 3.79x | ₩-17.09 Billion |
| 2020 | -98.47% | -80.58% | 0.32x | 3.80x | ₩-16.53 Billion |
| 2021 | -40.82% | -21.78% | 0.44x | 4.25x | ₩-6.28 Billion |
| 2022 | -148.37% | -36.72% | 0.52x | 7.77x | ₩-10.27 Billion |
| 2023 | -17.15% | -18.65% | 0.37x | 2.48x | ₩-7.86 Billion |
| 2024 | -2.45% | -4.51% | 0.29x | 1.86x | ₩-4.84 Billion |
Industry Comparison
This section compares Neofect Co.Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $76,459,143,483
- Average return on equity (ROE) among peers: -8.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neofect Co.Ltd (290660) | ₩26.86 Billion | 0.00% | 1.58x | $39.65 Million |
| Shinhung (004080) | $39.03 Billion | 19.75% | 1.29x | $88.50 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $262.71 Million |
| JVM Co. Ltd (054950) | $202.34 Billion | 14.26% | 0.41x | $194.75 Million |
| Huvitz Co. Ltd (065510) | $68.86 Billion | 9.49% | 0.66x | $56.91 Million |
| Vieworks Co. Ltd (100120) | $170.25 Billion | 13.45% | 0.16x | $166.59 Million |
| Corentec Co Ltd (104540) | $24.09 Billion | -123.57% | 1.67x | $50.95 Million |
| Humasis Co. Ltd (205470) | $16.13 Billion | -5.29% | 1.13x | $61.42 Million |
| NH SPAC 2 (206640) | $67.87 Billion | -3.16% | 0.59x | $167.83 Million |
| Hana Must SPAC 2 (208370) | $60.10 Billion | 8.60% | 0.11x | $74.07 Million |
| DRTECH Corporation (214680) | $72.77 Billion | -26.51% | 1.46x | $95.65 Million |
About Neofect Co.Ltd
Neofect Co., Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech me… Read more